The global monoclonal antibody therapy market is poised for remarkable growth, with projections indicating a substantial increase from USD 205 billion in 2022 to a staggering USD 479.2 billion by 2030. This growth trajectory represents an impressive compound annual growth rate (CAGR) of 11.2% over the forecast period spanning from 2023 to 2030. Get Sample  PDf...